Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
a novel technology platform of RALA mediated gene delivery via polymeric microneedles
Both semaglutide (brand names Ozempic, Wegovy) and tirzepatide (Mounjaro) are glucagon-like peptide-1 (GLP-1) receptor agonists that work by mimicking a hormone to reduce appetite, however tirzepatide uniquely also activates the glucose-dependent insulinotropic polypeptide (GIP) receptor unlike semaglutide which only activates the GLP-1 receptor
With just 2.4 mg doses, the semaglutide group lost an average of 16% of their body weight , while the placebo group only lost an average of 5.7%
Fiber-rich and nutrient-dense Whole foods like vegetables, legumes, and healthy fats help keep digestion smooth and support gut health both important on a GLP-1 journey
Moreover, like other medications in its class, there is a warning regarding the risk of thyroid C-cell tumors, based on animal studies, although its relevance to humans remains under investigation
